Prevalence of CYP2C8*2 and *3 among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment

BACKGROUND: In Eritrea, artesunate–amodiaquine is the first-line treatment against uncomplicated malaria. Amodiaquine, which is mainly bio-transformed by CYP2C8, is known to be associated with adverse events of different severity. Extrapyramidal events are among the less common but have been reporte...

Descripción completa

Detalles Bibliográficos
Autores principales: Habtemikael, Lidia, Russom, Mulugeta, Bahta, Iyassu, Mihreteab, Selam, Berhane, Araia, Mårtensson, Andreas, Gil, Jose Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669516/
https://www.ncbi.nlm.nih.gov/pubmed/33209048
http://dx.doi.org/10.2147/PGPM.S276215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669516/
https://www.ncbi.nlm.nih.gov/pubmed/33209048
http://dx.doi.org/10.2147/PGPM.S276215

Ejemplares similares